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Abstract
Breast cancer continues to remain a significant health issue for women.
Previously thought to only occur among postmenopausal women, breast cancer has
impacted women of different ages; and rates of breast cancer have various impacts
among different ethnic groups. For women living in a toxic environment, many of them
have become the new wave of breast cancer cases. Screening and detection have
succeeded in decreasing mortality rates. However, more research is needed in finding
an efficient method of treatment. In the effort to assist in the fight against breast cancer
through a policy and programmatic angle, I am fulfilling my internship at Breast Cancer
Prevention Partners. The organization has been active for 25 years engaging
community members in the fight against breast cancer. In the Program & Policy
Department, the work is centered around policy advocacy with regards to state and
federal regulations that impact environmental exposures for women and children. The
goal of the Campaign for Safe Cosmetics is to protect the health of consumers, workers,
and the environment through public education and engagement, corporate
accountability and sustainability campaigns, and legislative advocacy. This fieldwork
placement resulted in the Breast Cancer Prevention Partners drafting a public comment
to the FDA in response to their proposed lead maximum in lip cosmetics and external
cosmetics. Due to the ever-changing political climate in Washington D.C., the second
project did not come to pass. Anyone that is interested in this path must be cognizant of
the impact of an unstable political climate.
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I.

Introduction
Previously thought to only occur among post-menopausal women, breast cancer

has impact women of different ages. Breast cancer has had various impacts among
different ethnic groups. Years spent living in a toxic environment has created a new
source of breast cancer cases. Despite the ample amount of evidence found in toxic
exposure in rates of other types of cancer, my fieldwork intends to address and assist in
filling the gap of environmental exposures and rates of breast cancer incidence,
treatment, and mortality.
This form of cancer has traditionally been believed to occur only among postmenopausal women. However, through recent years we have seen a steady increase
among pre-menopausal women in the development of various forms of breast cancer.
Althuis et al. noticed a diverse range of causes in women less than 20 years of age
being diagnosed with ER+ or PR+ breast cancer (Althuis, et al., 2003). Factors such as
race, income level, oral contraceptive use, number of children, frequency of
mammograms, time of menarche, and proxy of relative with breast cancer were all
found to influence risk of developing breast cancer. Despite more research being
needed, this study found African American women at a particularly higher risk of
developing breast cancer regardless of age and contraceptive use, showing a relative
risk for women age 20-24 years at 2.49 and 2.42 for women 45-54. As our society
continues to progress in technological advancement, one needs to consider the
increase in exposure for women younger than 20 years of age. We may begin to see a
new trend of benign and aggressive cases of breast cancer among this group.
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Aside from this disease impacting different age groups, women of different ethnic
groups are also unequally impacted. Between 2003 and 2012, the CDC determined that
the incidence of breast cancer cases had remained level for White, American
Indian/Alaska Native, and Hispanic women; while for African American/Black and
Asian/Pacific Islander women the incidence rate increased by 0.8% and 1.1% per year
respectively (Centers for Disease Control and Prevention , 2016). The mortality rates
decreased among these ethnic groups, with the most significant difference being seen
in American Indian/Alaska Native women and the least being seen among Hispanic
women (Centers for Disease Control and Prevention , 2016). Sociodemographic factors
ranging from income and education status, to ethnicity and age have all influenced the
diagnosis, treatment, and survival rate.
It is easy for a medical professional to tell the patient to change their lifestyle to
reduce the risk of developing breast cancer; however, not considering the possible
barriers that may impede any progress is detrimental to the most vulnerable
populations. For example, in 2016 Smith et al. assessed the impact of high BMI among
African American women with rates of breast cancer recurrence. The analysis found
African American women with a BMI higher than 30kg/M were experiencing breast
cancer recurrence more often than women who could lower their BMI. This finding did
not coincide with survival rates, however women who were able to achieve a “healthier
weight” by following through on the diet recommendations by their doctors had a
successful rate of remission. Also, women who were categorized as obese were more
often diagnosed with late stage breast cancer (types IIIA, IIIB, and IV) (Smith, et al.,
2016). By not considering the barriers patients may encounter in attempting to follow
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medical recommendations such as living in a food desert where access to fruits and
vegetables is extremely rare; incidence and mortality rates among vulnerable groups
such as African American women with a high BMI will only increase.
Frequencies of gene expressions in certain subtypes of breast cancer have also
impacted the rates of survival. Ma et al. analyzed the expression of the p53 gene in
White, Hispanic, and African American women. Despite this gene arising in all three
groups, the expression in African American women lead to a significant impact on
mortality rates. His study found that African American women were more than likely to
die from breast cancer despite the various forms of treatment (Ma, et al., 2013).
Through variations in race, it is easy to simply assume that because a woman is African
American that she is more than likely to not survive from breast cancer. However, other
causes such as environmental exposure need to be considered.
Years spent living and working in a toxic environment has created a new source
of breast cancer cases. Women living on Cape Cod were found to have an increased
risk of breast cancer. In 2004 McKelvey et al. found that women who had lived on Cape
Cod for at least 5 years or more were at a higher risk of developing breast cancer.
Social determinant factors such SES, ethnicity, education, parity, age of menopause,
and proxy relative were all taken into consideration (McKelvey, Brody, Aschengrau, &
Swartz, 2004). Due to the historical use of pesticides such as DDT, the rates of cases
associated with women who lived in the area for 5+ years, the study highlights the everincreasing impact of environmental exposure on diagnosis. In 2007 Cohn et al.
analyzed DDT exposure and breast cancer risk among women during the 1940’s.
Investigators calculated the rate of exposure from the age of breast cancer diagnosis to
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the age when health data was collected. Despite that many of the women involved did
not reach the age of 50 when this study was conducted, the scientist still revealed very
interesting results. The results indicated that high levels of exposure predicted a
significant 5-fold increased risk of breast cancer among women that were born after
1931; meaning they were under the age of 14 while DDT was widely used (Cohn, Wolff,
Cirillo, & Sholtz, 2007). In 2012, the National Institute of Occupational Safety and Health
found that women working in the garment industry were at risk of developing myeloid
leukemia from persistent formaldehyde exposure. The more time spent in this industry
increased the risk of diagnosis (The National Institute for Occupational Safety and
Health (NIOSH), 2012). Despite the ample amount of evidence of environmental
exposure and cancer rates, there is very little information on the impact of toxic
exposure and breast cancer rates. My work with the Breast Cancer Fund is aimed at
filling this gap. Through my time with this organization, I intend to assist in finding and
spreading information related to toxic exposure in cosmetic & cleaning products.
Traditionally classified as a disease that impacts women of certain ages and
ethnic groups, this disease has begun to impact women of all ages and races. Factors
such as SES, BMI and educational status continue to be analyzed as causes in
variation of incidence and mortality. However, very little information has explained the
impact of environmental exposures from residence to occupation. It is this area of
causation in which my work intends to address.
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II.

Background
Over the years, a lot of work has been put into the fight against breast cancer.

There has been an emergence of new screening and detection methods. Although there
has been success in finding new methods of treatment and detection, more research is
needed. Using post-treatment methods such as breast reconstruction, the efficacy and
use has been called into question. Lastly, with these advancements there are many
areas that have not been effectively addressed.
The emergence of screening and detection has succeeded in decreasing overall
mortality rates. Wellings et al. compared the value of an MRI to that of a mammogram.
The use of mammograms has been contested with the promotion of an MRI for high risk
breast cancer patients. This review looks at the studies on rates of detection and costeffectiveness of an MRI and mammogram. For women with less dense breast tissue,
the mammogram is recommended as lesions are easily detected. However, women that
carry the BRCA1 or BRCA2 gene tend to have very dense breast tissue and are usually
diagnosed with more aggressive strains of breast cancer. It has been recommended
that doctors use an MRI as a standard method of screening & detection. The only issue
that has not been addressed is whether women in older age groups should go through a
mammogram as well as an MRI. The argument is that despite the MRI being more cost
effective, it is an unnecessary method as older women tend to have less dense breast
tissue (Wellings, Vassiliades, & Abdalla, 2016). In 2006, Plevritis and his colleagues
analyzed the cost effectives of an MRI for women with the BRCA1 and BRCA2 gene.
According to Plevritis et al., women that carry the BRCA1 gene will benefit more from an
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MRI than a mammogram. Considering different age groups and variations of BRCA1
and BRCA2 gene expression; it was found that women with the BRCA1 gene between
that ages of 45 and 65 would benefit the most from using an MRI. Despite the increase
in cost and the high rate of false-positives, this method of detection was found to
increase life expectancy (Plevritis, et al., 2006).
In addition to different methods of detection, the use of a mastectomy as a
preventative measure among women with a higher risk has been analyzed. Collins and
his colleagues found that the use of risk reducing mastectomy and other preventive
surgical methods was found to be beneficial in decreasing the incidence of breast
cancer among women 45 years of age and older. The drawbacks from this method stem
from complications during and after surgery, ranging from infection at the surgical
incision to body image concerns (Collins, et al., 2013). Despite the emergence of
screening and detection methods more research is needed in finding an efficient
method of treatment. Earlier this year, Yu et al. analyzed how the Star-PAP protein may
be the next step in breast cancer treatment. The scientists in this study found that the
Star-PAP protein plays a vital role in the development of tumor cells, but it is also
viewed as a possible suppressant. Tested through a handful of trials with databases
from all over China, this protein was found to influence the mitochondrial death of a
tumor cell. Through this, scientists have determined that targeting this protein via the
TUT1 gene during chemotherapy will improve the effects of treatment (Yu, et al., 2017).
Within the sphere of chemotherapy, there have been new findings in the use of
chemotherapy among different ethnic groups, as well as advancements in alternative
forms of treatment. Earlier this year Sheppard and colleagues noticed a wide variation
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in the rates of triple negative breast cancer and the use of chemotherapy among Black
and White women. The study found that women diagnosed with triple negative breast
cancer TNBC were more likely to be Black than White. As a result, the use of
chemotherapy was higher among Black women (Sheppard, et al., 2017). Despite the
increase in use of chemo among Black women the completion rate of chemotherapy
was higher among White patients. Also, women from both ethnic groups were found to
lower the use of chemo as their age increased. Scientists in this study guessed the
reason behind the disparities to be healthcare discrimination, age at diagnosis, and
stage of breast cancer. Women diagnosed with late stages (IIA, IIB, and IV) were less
likely to opt for chemo and happened to be at an older age (Sheppard, et al., 2017).
Also, earlier this year, Suryawanshi and her colleagues analyzed the efficacy of
oncolytic viruses (OV)as an option for breast cancer treatment. Like the mechanism of a
vaccine, the OV was found to attack the growth and replication process of the tumor cell
without the added toxic exposure risk of chemotherapy (Suryawanshi, Zhang, & Essani,
2017). Used as a single form of treatment, the oncolytic virus was not effective in
treating patients compared to chemotherapy. However, when used with other forms of
treatment such as chemo the virus showed a more successful result in treating patients
particularly one with invasive breast cancer. The primary concern of this use is
possibility of mutation and the mutation becoming ineffective in treatment, whether in
monotherapy or combination therapy (Suryawanshi, Zhang, & Essani, 2017).
Common practices in remission have called into question of what it means to be
a woman. The use of reconstructive surgery methods has become important in breast
cancer recovery. However, the benefits are varied among different groups. The trend of
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breast reconstruction after a mastectomy has increased over the years. Ilonza et al.,
analyzed the trends, different types of reconstruction, and the risks associated with
each. Out of all the different methods, the TRAM flap reconstruction carried the highest
risk of developing complications after surgery. The most popular and safer option was
the tissue expander (TE) method (Ilonzo, Tsang, Tsantes, Estabrook, & Thu Ma, 2017).
Though the TE method, women can continue cancer treatment immediate after surgery.
The study involved 67,450 patients through the National Surgical Quality Improvement
Program (NSQIP) database, and were followed from 2005 to 2014 (Ilonzo, Tsang,
Tsantes, Estabrook, & Thu Ma, 2017). External factors such as race, age,
socioeconomic status (SES), neurological state, and comorbidities were taken into
consideration. Despite African American women carrying the highest number of cancer
cases, they were least likely to undergo reconstruction after a mastectomy despite the
increase in procedure. Also in this study, older women were less likely to undergo
surgery while women 40 years and younger consisted of the largest portion of patients.
Aside from analyzing patient use of reconstructive surgery, medical professionals
were also surveyed. Earlier this year Coroneos and colleagues interviewed medical
professionals on their perspective of breast cancer reconstruction. The results of this
survey indicated that surgeons, oncologists, and plastic surgeons agreed on the
drawbacks of reconstructive surgery, specifically implant based reconstruction (IRB)
(Coroneos, et al., 2017). The delay in future treatment due to time spent in recovery
was found to increase the risk of additional tumors. Also, the IRB method of
reconstruction interfered with detection methods thus further increasing the patients risk
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of new tumors. The primary reason behind the issues of IRB was the lack of resources
from the national health department (Coroneos, et al., 2017).
Despite the advancements in breast cancer research, screening, and treatment
there is more work to be done. Laws and regulations on environmental & toxic
exposures has been one of the areas in need of more information. My time spent at the
Breast Cancer Fund focuses on the impact of environmental health regulation on the
state & federal level, research, and common preventative measures.
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III.

Scope of Work
In the effort to participate in the fight against breast cancer through a policy and

programmatic angle, I am fulfilling my internship requirement at Breast Cancer
Prevention Partners, formerly known as the Breast Cancer Fund in San Francisco, CA.
My work is housed primarily in the Program & Policy department, with some work in the
Science & Research department. The target population for both departments and the
organization is primarily women of reproductive and post reproductive age, and young
girls. Breast Cancer Prevention Partners targets consumers that are exposed to any
toxic chemicals that are linked to cancer and other long term health effects. BCPP
targets women and children of all ethnic groups and income levels that are exposed to
toxic chemicals linked to cancer and other long term effects. The geographic scope of
the organization is primarily within the state of California, however the joint efforts
through the Campaign for Safe Cosmetics serve women and children all over this
country. Despite being a national 501(c)3 organization, most staffers reside in San
Francisco with 17 men and women located in the main office, and three groups located
in CA and Washington DC serving as consultants and lobby groups. For my internship, I
was assigned two projects in two different departments aimed to strengthen the CSC
Business Network and successfully advocate for the CA Fragrance Disclosure Bill to
complete the implementation of the 2017 product testing initiative.
The organization has been active for 25 years engaging community members
locally and nationally in the fight against breast cancer. The mission of this organization
is to work to prevent breast cancer through eliminating the exposure to toxic chemicals
and radiation that is linked to the disease (The Breast Cancer Fund, 2016). They
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translate the growing body of scientific evidence linking breast cancer and
environmental exposures into public education and advocacy campaigns that protect
our health and reduce breast cancer risk. Also, the organization looks for practical
solutions so that future generations can thrive (The Breast Cancer Fund , 2015).
In Program & Policy, the work is centered around policy advocacy with regards to
state and federal regulations that impact environmental exposure for women and
children. Also, this department is the home of the Campaign for Safe Cosmetics. This
campaign works on market based work with small and large cosmetic and personal care
businesses in assisting political advocacy through being an example of a successful
green product manufacturer. The Science department is responsible for the annual
product testing, which tests some of the most common cosmetic, personal care, and
cleaning products on the market for toxic chemicals. Each year the hazardous chemical
in question is selected based off the proposed or supported state/federal legislation.
This year, the focus is on fragrances which has been known to cover hundreds of
harmful chemicals which are not reported by the businesses or manufacturers. Also,
this department is responsible for maintaining the accuracy of data in every study
conducted by Breast Cancer Prevention Partners.

Program and Policy Department
The Program and Policy Department is responsible for all programmatic and
policy work of Breast Cancer Prevention Partners. The work is divided amongst two
groups, the Program Team (with the consultation of Science Team), and the Policy
Team. The policy team works to develop, advocate for, and evaluate proposed and
current policies at the local, state and federal levels as they relate to environmental
14
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health, chemical regulation and exposure, and consumer right to know. The goal of the
policy team is to support health protective policies that reduce exposure to toxic
chemicals. The program team is responsible for managing two market-based
campaigns, the Campaign for Safe Cosmetics and Cans Not Cancer. These campaigns
include market-based advocacy in addition to legislative advocacy. The goals of the
Campaign for Safe Cosmetics are the same for Cans Not Cancer.
The goals for the project I am working on are to successfully advocate for the CA
Fragrance Bill and to complete the implementation of the 2017 Product Testing
initiative. The goals for my work within this project are the following, understanding how
market-based campaigns support state and federal policy initiatives and how market
campaigns are executed; understand current state and federal regulations on ingredient
disclosures in cosmetics and cleaning products; and to engage in strategic planning for
state and federal legislation related to fragrance disclosure. Looking at the ecological
model the organizational, community, and societal levels are involved in the first goal.
All three levels are addressed through my research which will focus on current and
previous campaigns on the county, state, and federal level. For the second goal, the
only ecological model level addressed is societal. Here I will be researching current
state and federal regulations on ingredient disclosures that will impact the U.S. and
influence international regulations. Like the first goal, the societal, community, and
organizational levels are addressed in the final goal. All three levels will be addressed
through my participation in meetings involving local and national organizations on state
and federal efforts. The site and players involved on all three goals are the Breast

15

Breast Cancer Policy

Cancer Prevention Partners, the Senior Policy Coordinator, the Director of Program &
Policy, and the Program and Outreach Manager.
My role in this project is under the same title of Program & Policy Intern. I am
providing support for the previously mentioned players involved. The activities I will be
doing are the following, assist the Science Department with chemical research on
California and Washington state databases to inform product testing; mapping potential
disclosure laws nationwide; participate in organizational strategic planning; participate
and support steering committee and other coalition convenings related to cosmetics
legislations. I will be assisting the product testing project through researching California,
Washington, and international databases for chemicals that are classified as a
fragrance. Once identified it is my job to research the health risks of each chemical. The
next two activities will occur through qualitative research on previous and current
legislation regarding fragrance disclosure laws and assessing the communications of
the organization with federal agencies such as the FDA. For the last activity, I will be
monitoring the progress of the proposed Affordable Care Act repeal & replacement bills;
and I will be monitoring the progress regarding the dismantling of the EPA. The
projected outcomes of the activities are the following, a completed research excel sheet
of chemicals in fragrances; a summary document of federal and state disclosure
regulations and potential new legislations; and a completed draft of a public comment to
the FDA’s Lip Cosmetics & External Cosmetic Lead Level Industry Guidance.
Through the immense and complex amount of work being done at Breast Cancer
Prevention Partners, it is with great hope that we will be one step closer to preventing
future loss from breast cancer. It is through this organization that the intention to assist
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researchers and medical professionals through making a difference in the impact of
breast cancer on the most vulnerable populations will yield a successful result.

Campaign for Safe Cosmetics
The goal of the Campaign for Safe Cosmetics (CSC) is to protect the health of
consumers, workers, and the environment through public education and engagement,
corporate accountability and sustainability campaigns and legislative advocacy
designed to eliminate dangerous chemicals linked to adverse health impacts from
cosmetics and personal care products (Campaign for Safe Cosmetics, 2017). The CSC
Business Network is a collaborative of retailers, manufacturers, formulators, business
owners and other members of the cosmetics and personal care products industry that
support the mission and goals of the Campaign for Safe Cosmetics. The goals of the
business network are to, stimulate the innovation of safe, non-toxic personal care
products that the world market is demanding; protect consumers, workers and the
environment from exposure to chemicals linked to cancer, reproductive harm and other
adverse health impacts; and to ensure everyone in the U.S. has access to safe personal
care products, regardless of geography and income (Campaign for Safe Cosmetics,
2017).
In this project, my objectives are to learn the best practices for communication
with current and potential business network members; develop an orientation
onboarding process and toolkit for CSC business network members; and to understand
the strategy and process around rebuilding the coalition of endorsing organizations. In
the first objective, the parent organization Breast Cancer Prevention Partners, the
Program Director, and the Program Outreach Manager are involved in supervising my
17
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work. On the ecological model my work involves the following levels individual,
interpersonal, organizational, and community. For the individual and interpersonal
levels, I will be learning how to create an orientation pamphlet and I will learn how to
develop an onboarding process through communicating and shadowing with the
department director and the Program & Outreach Manager. The community and
organizational levels will be accomplished through the implementation of the orientation
packet and onboarding process with the toolkit. I will be the point of contact for business
owners, retailers, and other organizations regarding inquiries of new initiatives and
meetings spear headed by the campaign. Through this objective, I will be shadowing my
supervisors in how they communicate with members and facilitate the orientation allcalls. In the last objective, the previously stated players and site will be involved.
My role as the program and policy intern is to provide support for the director of
the Program and Policy Department and the Program & Outreach Manager. The
internship responsibilities are as follows, manage communication with the CSC
business network; respond to inquiries and other messages from the business
community; develop an onboarding process; develop orientation materials; develop a
blogger network within CSC; and provide outreach to current and new coalition
members. The first two activities will take place through monitoring the CSC business
network email daily. The onboarding process and orientation materials will be done
through consolidating the many contact lists, and attending the monthly orientation
phone calls. Developing a blogger network and providing outreach to current and new
coalition members, will take place through updating the contact list of business network
members. The outcomes of my activities are as follows, an updated “Master List” of
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CSC coalition members; a creation of orientation and onboarding materials; an
established blogger network and a set of processes to support the network; and the
creation of outreach communication materials. The intended audience for these
outcomes are the consumers of personal care and cleaning products whom are at risk
of developing cancer from exposure to toxic chemicals.
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IV.

Public/Population Health Impact: Findings and Significance
This fieldwork placement resulted in Breast Cancer Prevention Partners drafting

a public comment to the FDA in response to their proposed lead maximum in lip
cosmetics and external cosmetics. Another result of this fieldwork placement is the
creation of an onboarding toolkit for new businesses and new endorsing organizations
to the Campaign for Safe Cosmetics Business Network. The FDA public comment
revealed a lot of information regarding the loopholes in federal regulation for cosmetic
companies. However, more work is needed to accomplish the goal of erasing toxic
ingredients from cosmetic products. Due to the transition to the Trump Administration
and the ever-changing political climate in Washington, the onboarding toolkit for the
program did not come to pass.

Policy Project Outcome
The first outcome of my time with Breast Cancer Prevention Partners was the
public comment drafted by the organization to the FDA in response to its “Lead in Lip
Cosmetics & External Cosmetics Draft Guidance.” The first finding from this result was
the permissible concentration level of toxic chemicals like lead that were present in high
priced and affordable lip & external cosmetic products. The recommended maximum
level for the cosmetic industry drafted by the FDA was 10 ppm. My research on
permissible levels of lead in cosmetic products indicated that the international
community has not only a lower maximum level but also indicate that no level of lead is
safe. Due to my research on studies regarding the rate of ingestion and the health
impact; my finding which was stated in the public comment suggested a lower maximum
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level to that of 0.02ppm. In addition, through analyzing the instances of communication
between the FDA and BCPP I noticed that any studies conducted by the organization or
any of their partners were found insufficient by the federal agency. As required work
prior to drafting the public comment, I read the supplemental information provided by
the FDA which included their studies and results justifying the proposed maximum level.
Despite the ample amount of evidence from their four studies, none of them considered
the health impact of ingesting lead from lip cosmetics and external cosmetics.
The second finding from this result was the difficulty in manufacturing naturally
derived products at a low cost. Through my research, I found that cosmetic companies
that used naturally derived ingredients in their products had to price their stock at a
higher amount due to federal regulation allowing synthetic and often harmful chemicals
to be used at a lower cost. Thus, women of low socioeconomic status were unable to
decrease their level of risk due to the high price of safer products.

Campaign for Safe Cosmetics Outcome
Due to efforts by the Trump Administration to defund the Environmental
Protection Agency and to replace the Affordable Care Act, the onboarding tool kit for
new business members was not developed. The finding from this result was the
influence of politics in Washington D.C. on the work of nonprofit organizations. Due to
the influence of federal funds for program initiatives, anyone who chooses to venture
into this line of work will need to be aware of how changes in Washington will shift the
organization’s initiatives and efforts.

Policy Next Steps
21
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The FDA public comment revealed a lot of information regarding the loopholes in
federal regulation for cosmetic companies. However, more work is needed to
accomplish the goal of erasing toxic ingredients from cosmetic products.
More research is needed in finding out how toxic chemicals like lead in cosmetic
products impact the risk of endocrine disruption, specifically for young women and girls.
The findings from the supporting studies along with trials conducted by the FDA prove
that more search is needed into the long-term health impact of lead exposure through
lipstick and external cosmetic use. Also, research is needed on assessing the health
impact on women of low SES as many toxic free products are unaffordable.
One program next step is the opportunity to develop an educational program for
elementary and middle school students on the harmful effects of toxic chemicals in
makeup. This program can go into schools and/or partner with after school programs to
conduct education workshops showing what toxic chemicals are in our makeup and
personal care products. The end goals of this program are to have the students
remember to read the product label, and to successfully remember the names of the
“toxic trio” which are Formaldehyde, Dibutyl Phthalate (DBP), and Toluene.
On the policy level, more regulation is needed in reducing the use of toxic
chemicals like lead in cosmetic products. Closing the loopholes and increasing federal &
international oversight will assist in decreasing the presence of these harmful chemicals
in cosmetic products. Second, the advocacy of the European model of precautionary
testing before an item is placed on the market will be substantial in decreasing exposure
risk. Lastly, creating a policy that advocates for naturally derived chemicals in
replacement of synthetic ingredients, and creating a tax break for companies that use
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toxic-free ingredients; will assist in decreasing the price of eco-friendly cosmetics thus
giving women and girls of low SES the opportunity to decrease their risk of toxic
chemical exposure. Creating an incentive for companies will encourage more
manufacturers and thus the cosmetic industry to consider using cleaner ingredients in
all their personal care products.
Drafting the public comment on behalf of Breast Cancer Prevention Partners
exposed me to the numerous discrepancies and nuances of the federal government. To
many, the thought of federal oversight is an unwelcomed idea. However, through this
process I have learned that advocating for policy changes that assist in easier access to
healthier products helps in reducing the risk of breast cancer among the most
vulnerable groups such as minorities and women of low socioeconomic status. Despite
the inability to create the toolkit for new businesses joining the Campaign for Safe
Cosmetics; I experienced the level of vulnerability that many organizations and health
entities deal with in response to shifting changes in Washington D.C.

Program Next Steps
Working with an organization that is rooted in environmental health for women
with breast cancer and for those at risk on the policy advocacy level; the outcomes
stemming from Capitol Hill have had an immense impact on the work being done. For
anyone that chooses to take on this type of work, I recommend that one remains vigilant
to what is happening not only the state but federal level. Paying close attention to
federal agencies like the EPA, FDA, and Energy & Commerce will be extremely helpful
in circumnavigating any future obstacles.

23

Breast Cancer Policy

V.

Conclusion
Over the years, breast cancer has continued to remain a significant health

problem for women. The rates of breast cancer have varied among women of all ages
and ethnic groups. Evidence has also been found sourcing toxic environmental
exposures as the possible cause. A lot of work has been put into the fight against breast
cancer. There have been different methods of treatment; however, despite the
advancements, there is more work to be done.
Breast Cancer Prevention Partners, formerly known as the Breast Cancer Fund
has been in the fight against breast cancer for 25 years. Their mission is to connect the
dots between breast cancer research and exposure to chemicals & radiation in our
everyday environments (The Breast Cancer Fund, 2016). Their target population is
consumers that are exposed to chemicals linked to cancer and other long term health
effects.
The work at Breast Cancer Prevention Partners focused on assisting the
rebuilding & strengthening of the Campaign for Safe Cosmetics Coalition (CSC). Also,
my work focused on advocating, developing, and evaluating proposed & current policies
at the local, state and federal level as they relate to environmental health, chemical
regulation & exposure, and consumer right to know (Campaign for Safe Cosmetics,
2017).
The outcome of the internship at Breast Cancer Prevention Partners was a public
comment in response to the FDA’s Draft Industry Guidance on Lead in Lip Cosmetics
and External Cosmetics. Stemming from this result, more research is needed in finding
out how toxic chemicals like lead in cosmetic products impact the risk of breast cancer.
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There is also an opportunity to develop an educational program for elementary and
middle school students on the harmful effects of toxic chemicals in makeup. Lastly,
more regulation is needed in reducing the use of toxic chemicals like lead in cosmetic
and personal care products. Closing the loopholes and increasing federal &
international oversight will assist in decreasing the presence of these harmful
chemicals.
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Appendix A
Overall Reflection
My time spent at Breast Cancer Prevention Partners was an immense time of
growth. Being at the organization during the onset of the Trump administration was a
powerful example of how the political climate in Washington D.C. can impact the work
and livelihood of a group of women in San Francisco, CA. After coming to the
internship with zero experience or interest in policy, I am leaving with a newfound
respect and admiration for the role policy plays in every aspect of our lives. Through
my time here I now have a renewed passion to continue work within a field I am not
only passionate about but truly believe can uplift and sustain my community.
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Appendix B
Final Fieldwork Objectives

Goal 1: Learn how campaigns are planned and built in relation to federal & state policy regarding Environmental Health
Objectives (S)
Activities
Start/End Date
Who is Responsible
Tracking Measure
Understand how
Planning meetings for
(end)2/14/2017
Sara Schmidt
Participation in
market-based
Unilever Day of Action
meetings
campaigns support
(end)2/14/2017
Sara Schmidt
Developing resources
Development of
state and federal policy
and materials for Day of
materials
initiatives; and how
Action
market campaigns are
Connie Engle
Research will be
planned and executed
(start)2/1/17
(TBD) assist Science
completed
department with
chemical research on CA
and WA state databases
to inform product
testing
Understand current
state and federal
regulations on
ingredient disclosures
in cosmetics and
cleaning products

Mapping of potential
disclosure laws
nationwide

(start)3/3/2017

Nancy Buermeyer, Sara
Schmidt

Summary document of
federal and state
disclosure regulations
and potential new
legislation

Engage in strategic
planning for state and
federal legislation
related to fragrance
disclosure

Participate in
organizational strategic
planning

(start)2/10/2017

Sara Schmidt

Participation in
meetings

Participate and support
steering committee and
other coalition
convenings related to
cosmetics legislation
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Goal 2: Assist in building and strengthening the Campaign for Safe Cosmetics coalition (CSC)
Objectives (S)
Activities
Start/End Date
Who is Responsible
Tracking Measure
Learn best practices for
communication with
current and potential
business network
members

Manage communication
with CSC business
network

1/6/2017

Sara Schmidt

Respond to inquiries
and other messages
from the business
community

1/10/2017

Sara Schmidt

Develop orientation and
onboarding process and
toolkit for CSC business
network

Develop onboarding
process

2/16/2017

Sara Schmidt

Develop orientation
materials

2/17/2017

Sara Schmidt

Understand strategy
and process around rebuilding coalition of
endorsing organizations

Develop blogger
network within CSC

3/2/2017

Sara Schmidt

Outreach to current and
new coalition members

2/1/17

Sara Schmidt

Orientation to business
network
Ongoing email
communication

Draft and final versions
of onboarding and
orientation materials

Established blogger
network and set of
processes to support
the network
Outreach
communication
materials
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Appendix C
Master of Public Health Program FIELDWORK TIME LOG
Student
InIII nf o r ma t io n
Campus ID # 20355386

Student’s Name: Nandi Robinson
Student’s Phone: 510-294-9274

Student’s Email: nmrobinson@dons.usfca.edu
Preceptor
Information

Preceptor’s Name: Sara Schmidt

Preceptor’s Title: Outreach & Organizing Manager

Preceptor’s Phone: 415-744-4675

Preceptor’s Email: sara@bcpp.org

Organization: Breast Cancer Prevention Partners, formerly known as Breast Cancer Fund
Student’s Start Date: January 3, 2017

Student’s End Date: Hours/week: April 14, 2017: 20 hours

Time Log for (Check One):
_________________ Summer 2016

_____________________Fall 2016

_____________X____ Spring 2017

Week
Jan 3- Jan 6
Jan 9 – Jan 13
Jan 17 – Jan 19
Jan 24 – Jan 28
Jan 31 – Feb 3
Feb 7 – Feb 10
Feb 14 - Feb 17
Feb 20 – Feb 24
Feb 27 – Mar 4
Mar 6 – Mar 11
Mar 13 – Mar 17
Mar 20 – Mar 24
Apr 3 – Apr 7
Apr 10 – Apr 14

_____________________Summer 2017

Total # of Hours for Week
28
28
21
35
19
24
20.25
20
22.5
29
17
15
17
13

Preceptor Initials
S.S.
S.S.
S.S.
S.S.
S.S.
S.S.
S.S.
S.S.
S.S.
S.S.
S.S.
S.S.
S.S.
S.S.

31

Breast Cancer Policy

Appendix D
Student Evaluation of Field Experience
Student Information
Student’s Name: Nandi Robinson
Student’s Phone: 510-294-9274

Campus ID # 20355386
Student’s Email: nmrobinson@dons.usfca.edu
Preceptor Information

Preceptor’s Name: Sara Schmidt

Preceptor’s Title: Program & Outreach Manager

Preceptor’s Phone: 415-744-4675
Organization: Breast Cancer Prevention Partners

Preceptor’s Email: sara@bcpp.org

Student’s Start Date: January 3, 2017

Student’s End Date: Hours/week: April 14, 2017: 20 hours

Please use the following key to respond to the statements listed below.
SA = Strongly Agree A = Agree D = Disagree SD = Strongly Disagree N/A = Not Applicable
My Field Experience…
Contributed to the development of my specific career interests

SA

A

D

SD

N/A

Provided me with the opportunity to carry out my field learning objective activities

SA
SA

A
A

D
D

SD
SD

N/A
N/A

SA

A

D

SD

N/A

SA

A

D

SD

N/A

SA
SA
SA
Yes

A
A
A

D
D
D

SD
SD
SD
NO

N/A
N/A
N/A

Was accessible to me

SA
SA

A
A

D
D

SD
SD

N/A
N/A

Initiated communication relevant to my special assignment that he/she considered of
interest to me

SA

A

D

SD

N/A

Initiated communication with me relevant to general functions of the agency

SA

A

D

SD

N/A

Provided the opportunity to use skills obtained in MPH classes
Required skills I did not have
Please list:
Required skills I have but did not gain in the MPH program
Please list:
Added new information and/or skills to my graduate education
Please list: drafting a public comment/statement to a federal
agency.
Challenged me to work at my highest level
Served as a valuable learning experience in public health practice
I would recommend this agency to others for future field experiences.
My preceptor…
Was valuable in enabling me to achieve my field learning objectives
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2. Would you recommend this preceptor for future field experiences? Please explain.
X

Yes

No

Unsure

Sara was a great preceptor, she made sure I could work on projects or subjects that interested me. Her door was
always open to questions and concerns. She was patient with me on every task I did.

3. Please provide additional comments explaining any of your responses.
I highly recommend anyone that is interested in the field of Breast Cancer research, environmental health, or policy
advocacy to consider interning with this organization. Keep in mind, this internship is unpaid.

4. Summary Report: All students are required to prepare a written summary of the
field work to be submitted with this evaluation form.

Nandi Makeda Robinson

April 13, 2017

Student Signature

Date
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Appendix E
MPH Program Competency Inventory
USF MPH COMPETENCIES

HOW MY PROJECT ACHEIVES THOSE
COMPETENCIES
Discuss multiple dimensions of the policyThe FDA Public Comment on Lead and
making process, including the roles of ethics
Lipstick Industry Guidance addresses the ethics
and evidence
and evidence in policy and regulation
development. Also, the evidence from the
annual cleaning and personal care product
testing conducted by the Breast Cancer Fund
will assist the CA Fragrance Disclosure Bill
which is backed by the organization. My role
for both projects is to provide support through
research of fragrance chemicals and to conduct
a literature review of domestic and
international policies & regulations.
Evaluate policies for their impact on public
The FDA Public Comment I drafted evaluates
health and health equity
previous domestic and international regulations
on lead and other carcinogenic exposures in
cosmetic products.
Communicate audience-appropriate public
I developed a template for the Campaign for
health content, both in writing and through oral Safe Cosmetics Business Network and
presentation
Endorsing Organizations on drafting a public
comment in support of BCPP policy advocacy.
I will also be assisting the monthly orientation
all-calls for CSC businesses which will provide
members with up to date information
pertaining to public health policy.
Perform effectively on interprofessional teams My project overlaps the Program, Policy, and
Science Departments at the Breast Cancer
Prevention Partners. From advocacy work on
the Fragrance Disclosure Bill to the annual
product testing, I am in correspondence with all
three.
Apply systems thinking tools to a public health My work with the Program, Policy, and
issue
Science departments involve the interpersonal,
organizational, community, and national levels.
For the interpersonal and organizational levels,
I am working for the Campaign for Safe
Cosmetics and will be in correspondence with
CSC business members regarding policy
actions BCPP is involved in. The community
and national levels are found in my
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Select communication strategies for different
audiences and sectors

involvement with advocacy work for the
Fragrance Disclosure Bill and through my
work on the FDA Public Comment which
received support from more than 150
organizations representing 9 million people.
I developed two public comment guides for
Campaign for Safe Cosmetics Business
Network Members and BCPP Partners. Each
guide composed of a template of where to
submit their comment, how to draft, and
several talking points to use.
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